The UCSF School of Pharmacy has entered into a five-year collaborative education and research agreement with Tsinghua University School of Medicine in Beijing, China.
The agreement will establish a joint Tsinghua School of Medicine-UCSF School of Pharmacy program for pharmacology and pharmaceutical sciences education and research at Tsinghua University, which is one of China’s top science and engineering schools.
UCSF, Harvard University, and Stanford University have been ranked as the top three world universities in the broad subject fields of clinical medicine and pharmacy in the 2010 Academic Ranking of World Universities (ARWU), which was released on August 15, 2010, by the Center for World-Class Universities of Shanghai Jiao Tong University. UCSF has remained among the top three universities in clinical medicine and pharmacy since this ranking category was introduced by ARWU in 2007.
The UCSF School of Pharmacy was a key collaborator in the early January 2009 launch of a course in China that ultimately hopes to contribute to the improved quality and broader acceptance of Chinese pharmaceuticals and pharmaceutical exports.
The New York-based Li Foundation, which for more than 15 years has been supporting Chinese scientists to study at UCSF, is now targeting its support to scholars from Peking University's Center for Theoretical Biology to study at the University of California's (UC's) California Institute for Quantitative Biomedical Research (QB3), which is headquartered at UCSF. At QB3, Peking scientists will work in the area of systems biology.
Using standards that measure a university's openness and diversity, as well as distinction in research, Newsweek International ranked UCSF 9th among the top 100 global universities as reported in the publication's August 13, 2006 online issue. "The public we now serve is increasingly a global public, and this ranking is one measure of our success," comments UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD.
A research collaboration between the University of California (UC) and Peking University will integrate the biological data acquisition strengths of the former with the physical and theoretical strengths of the latter, a move which scientists anticipate will ultimately lead to more effective, safer medications for populations and individuals.